MAP2K1 and Langerhans cell histiocytosis: We investigated the predictive values of CBCs, BRAF V600E, and MAP2K1 in 71 childhood LCH, and evaluated a new risk model that combined with CBCs, BRAF V600E, and MAP2K1 for prognostic prediction of childhood LCH patients.